Analyze Diet

Topic:Piroplasmosis

Piroplasmosis is a tick-borne disease affecting horses, caused by the protozoan parasites Theileria equi and Babesia caballi. These parasites invade and multiply within the red blood cells of the host, leading to hemolytic anemia. Clinical signs of piroplasmosis in horses may include fever, lethargy, jaundice, and anemia, although some horses may remain asymptomatic carriers. Diagnosis is typically confirmed through blood tests, including serological assays and polymerase chain reaction (PCR) techniques. Piroplasmosis can impact equine health and performance, and it poses challenges for international horse movement due to quarantine regulations. This page compiles peer-reviewed research studies and scholarly articles that explore the epidemiology, pathogenesis, diagnostic methods, and management strategies for equine piroplasmosis.
Equine piroplasmosis: a review.
The British veterinary journal    January 1, 1992   Volume 148, Issue 1 6-14 doi: 10.1016/0007-1935(92)90061-5
de Waal DT.This review focuses on equine piroplasmosis with specific reference to its distribution, diagnosis and clinical and pathological signs. The more common used drugs are discussed both with reference to treatment and chemosterilization. Areas requiring further research are also briefly mentioned.
A monoclonal antibody defines a geographically conserved surface protein epitope of Babesia equi merozoites.
Infection and immunity    July 11, 1991   Volume 59, Issue 7 2412-2417 doi: 10.1128/iai.59.7.2412-2417.1991
Knowles DP, Perryman LE, Goff WL, Miller CD, Harrington RD, Gorham JR.Babesiosis is a tick-borne hemoparasitic disease affecting horses worldwide. To investigate mechanisms of immunity to this parasite, the antibody response of infected horses to Babesia equi merozoite proteins was evaluated. Immunoprecipitation of B. equi merozoite antigens with sera from infected horses revealed 11 major proteins of 210, 144, 108, 88, 70, 56, 44, 36, 34, 28, and 25 kDa. Monoclonal antibody (MAb) 36/133.97, which binds to live merozoites, immunoprecipitated proteins of 44, 36, 34, and 28 kDa. When immunoprecipitations were performed with in vitro translation products of merozoi...
Enrichment of Babesia caballi-infected erythrocytes from microaerophilous stationary-phase cultures using Percoll gradients.
Parasitology research    January 1, 1991   Volume 77, Issue 2 177-179 doi: 10.1007/BF00935433
Bhushan C, Müller I, Friedhoff KT.A rapid and simple method for concentrating leucocyte-free Babesia caballi-infected erythrocytes from in vitro cultures is described. Infected erythrocytes amounted to at least 95% of all red cells obtained.
Evaluations of buparvaquone as a treatment for equine babesiosis (Babesia equi).
American journal of veterinary research    May 1, 1989   Volume 50, Issue 5 782-785 
Zaugg JL, Lane VM.We evaluated the efficacy of buparvaquone in eliminating Babesia equi of European origin in carrier horses and in experimentally infected splenectomized ponies. When administered at the rate of 2.5 mg/kg of body weight, IM, 4 times at 96-hour intervals, buparvaquone was effective in eliminating B equi carrier infection in 1 horse. Such results could not be repeated at the same dosage or at 3.5 or 5 mg/kg, IM. Buparvaquone given at the rate of 4 to 6 mg/kg IV and/or IM was therapeutically effective in 4 of 5 acute B equi infections in splenectomized ponies. The treated ponies became carriers.
Repetitive DNA probes for the detection of Babesia equi.
Molecular and biochemical parasitology    April 1, 1989   Volume 34, Issue 1 75-78 doi: 10.1016/0166-6851(89)90021-2
Posnett ES, Ambrosio RE.This report describes DNA probes for the identification of Babesia equi. A genomic library of B. equi was constructed in pUC13. Several clones were identified that hybridized strongly to B. equi DNA. Clone pBE33 hybridized specifically to B. equi DNA and did not hybridize to horse DNA nor to DNA from Babesia caballi, Babesia bovis or Babesia bigemina. Two subclones of pBE33 (pSB20 and pEH21) containing B. equi repetitive sequences, could detect 0.49 ng and 0.97 ng B. equi DNA, respectively.
Prevalence of piroplasmosis in equines in the Colombian province of Cordoba.
Tropical animal health and production    May 1, 1988   Volume 20, Issue 2 93-98 doi: 10.1007/BF02242234
Tenter AM, Otte MJ, Gonzalez CA, Abuabara Y.Eighty-two equine sera from 13 farms in northern Colombia were examined for antibodies to Babesia caballi and B. equi using the complement fixation (CF) and the indirect fluorescent antibody (IFA) test. Seroreactors to both piroplasms were present on all farms. The IFA test indicated a prevalence of 90% for B. caballi and 94% for B. equi. The CF test detected antibodies to B. caballi in 41% and to B. equi in 65% of the animals. The prevalence of seroreactors in different age groups revealed a significant decline in CF antibodies to B. caballi in animals older than three years. IFA titres for b...
Isolation of pure Babesia equi and Babesia caballi organisms in splenectomized horses from endemic areas in South Africa.
The Onderstepoort journal of veterinary research    March 1, 1988   Volume 55, Issue 1 33-35 
De Waal DT, Van Heerden J, Van den Berg SS, Stegmann GF, Potgieter FT.Both Babesia equi and Babesia caballi are endemic in large parts of South Africa. Attempts were made to obtain pure local isolates of both B. equi and B. caballi for the purpose of developing serological tests to study the epidemiology of equine babesiosis in this country. The indirect fluorescent antibody test was used to screen horses for B. equi and B. caballi in an endemic area. Seven horses and 3 donkeys between 3 and 36 months of age that tested negative were subsequently splenectomized. The splenectomy operation was performed through the abdominal approach. A 100% survival rate was achi...
Imidocarb and parvaquone in the treatment of piroplasmosis (Babesia equi) in equids.
American journal of veterinary research    November 1, 1987   Volume 48, Issue 11 1613-1616 
Kuttler KL, Zaugg JL, Gipson CA.The therapeutic efficacies of imidocarb and parvaquone were tested against Babesia equi of European origin in carrier horses and for induced acute infections in splenectomized ponies. Imidocarb, at a dosage of 4 mg/kg of body weight, given IM at 72-hour intervals 4 times, was ineffective in eliminating B equi-carrier infection in 9 mature geldings. A single IM administration of 4 mg/kg was not therapeutic in acutely infected splenectomized ponies. When given at 3 different dosages and treatment schedules, parvaquone was ineffective in clearing carrier infection. Parvaquone given IM once at a d...
Serodiagnosis of experimental and natural Babesia equi and B. caballi infections.
Veterinary parasitology    March 1, 1986   Volume 20, Issue 1-3 49-61 doi: 10.1016/0304-4017(86)90092-0
Tenter AM, Friedhoff KT.The sensitivity and specificity of the complement fixation (CF) test for the diagnosis of Babesia infections in equines was assessed, using the indirect fluorescent antibody (IFA) test as a reference. Antibodies were first detected between 11 and 20 days post infection (dpi) in the CF test and between 7 and 14 dpi in the IFA test in ponies infected experimentally with B. equi (USDA strain). The CF test became negative in four of five ponies 63-174 dpi although B. equi was demonstrated microscopically in two of these four ponies up to 364 and 455 dpi. The IFA test remained positive up to 476 dp...
Species-specific serodiagnosis of equine piroplasma infections by means of complement fixation test (CFT), immunofluorescence (IIF), and enzyme-linked immunosorbent assay (ELISA).
Veterinary parasitology    March 1, 1986   Volume 20, Issue 1-3 43-48 doi: 10.1016/0304-4017(86)90091-9
Weiland G.The increasing horse trade requires a reliable immunodiagnosis of equine piroplasma infections due to import restrictions imposed by various countries, including the United States of America. It was the aim of our investigations to establish the suitability of serological tests for the detection of parasite carriers and, eventually, to differentiate between Babesia caballi and B. equi infections. The investigations were carried out on 11 ponies with experimentally-induced B. caballi and/or B. equi infection. The infections were confirmed by the demonstration of parasites in blood smears 2-13 d...
[Serodiagnosis and therapy control of equine piroplasmosis by CFT and IFAT].
Berliner und Munchener tierarztliche Wochenschrift    October 1, 1984   Volume 97, Issue 10 341-349 
Weiland G, Aicher BM, Boch J.No abstract available
Use of schizont and piroplasm antigens of Babesia equi in the indirect fluorescent antibody and complement fixation tests.
Veterinary parasitology    May 1, 1983   Volume 12, Issue 2 135-144 doi: 10.1016/0304-4017(83)90002-x
Rehbein G, Heidrich-Joswig S.Eight ponies infected with Babesia equi were investigated for their serological response to B. equi schizont and piroplasm antigen with the indirect fluorescent antibody test (IFAT) and complement fixation test (CFT). Piroplasm antigen was prepared from an infected splenectomized pony, while schizont antigen was produced from cultured lymphoid cells which contained B. equi macroschizonts. The IFAT detected a rise in antibody titres to schizont antigen as well as to piroplasm antigen, but differences were obtained in the duration of antibody detection. Significant antibody titres to piroplasm a...
Cell-mediated immune response to Babesia equi-transformed lymphoblastoid cells in vitro. Zweygarth E, Ahmed JS, Rehbein G, Voigt WP.The capacity of equine peripheral blood lymphocytes (PBL) to proliferate in the presence of Babesia equi-transformed lymphoblastoid stimulator cells was tested in an autologous as well as in an allogenic one way mixed lymphocyte reaction (MLR). It was found that both autologous and allogeneic responder lymphocytes incorporated high amounts of 3H-thymidine. The incorporation of 3H-thymidine was lower in MLR using as stimulator cells lymphocytes from which the cell line had previously been established, than when using parasitized culture cells as stimulator. Proliferation of PBL was achieved onl...
Fine structure of Babesia equi Laveran, 1901 within lymphocytes and erythrocytes of horses: an in vivo and in vitro study.
The Journal of parasitology    February 1, 1983   Volume 69, Issue 1 111-120 
Moltmann UG, Mehlhorn H, Schein E, Rehbein G, Voigt WP, Zweygarth E.The development of Babesia equi (Piroplasmia) in the vertebrate host was studied by electron microscopy. The tick-borne sporozoites initiated an exoerythrocytic schizogony in lymphocytes in vivo and in vitro. In lymphocyte cultures the schizonts of B. equi lay as fissured bodies directly within the host cell forming numerous cytomeres. These cytomeres were bordered by a single membrane and contained polymorphous nuclei. Merozoite differentiation was initiated at several places by protrusions appearing at the periphery of the cytomeres. The cytoplasm of the schizont merged progressively into th...
[Piroplasmas of horses–impact on the international horse trade].
Berliner und Munchener tierarztliche Wochenschrift    October 1, 1982   Volume 95, Issue 19 368-374 
Friedhoff KT.No abstract available
Evidence of maternal antibodies to Babesia equi and B caballi in foals of seropositive mares.
Equine veterinary journal    April 1, 1982   Volume 14, Issue 2 126-128 doi: 10.1111/j.2042-3306.1982.tb02365.x
Donnelly J, Phipps LP, Watkins KL.No abstract available
Complement fixation tests for equine piroplasmosis (Babesia equi and B caballi) performed in the UK during 1976 to 1979.
Equine veterinary journal    April 1, 1981   Volume 13, Issue 2 103-106 doi: 10.1111/j.2042-3306.1981.tb04127.x
Joyner LP, Donnelly J, Huck RA.The results of complement fixation (CF) test for equine piroplasmosis on sera from horses destined for international movement from Great Britain and Ireland are presented and analysed. No horses born and continuously resident in the British Isles were found carrying CF antibodies to either Babesia equi or B caballi. Positive animals were found to have association with the following countries where known tick vectors occur: Spain, Portugal, Belgium, France, Poland, USSR and Arabian Gulf countries. Data on the persistence of CF antibodies in animals subjected to repeated testing showed that some...
Quantitative epidemiological studies on the prevalence of babesiosis in horses in Kuwait.
Tropical animal health and production    November 1, 1980   Volume 12, Issue 4 253-258 doi: 10.1007/BF02236625
Donnelly J, Joyner LP, Frank C.Racehorses imported into Kuwait were tested for serum antibodies to Babesia equi and B. caballi by complement fixation (CF) and indirect fluorescent antibody (IFA) tests. The prevalence of B. equi was high (77.1% by IFA) whereas that of B. caballi was much lower (11.4%). Data for B. equi showed that infection was acquired after about 6 months at risk and that in the following 12 months animals had antibody levels detectable by both CF and IFA tests by 24 months the CF reaction was no longer detectable. Estimates of incidence and inoculation rates were calculated and found to be consistent with...
Some aspects of the epidemiology of equine babesiosis.
Journal of the South African Veterinary Association    December 1, 1979   Volume 50, Issue 4 308-310 
Littlejohn A, Walker EM.The sex, coat colour, age, province and month of occurrence of every case of babesiosis was recorded in a horse population of 5856 in South Africa and Rhodesia. A total of 115 cases were recorded during the period 1973-01-01 to 1973-12-31. Chisquared tests were used to evaluate the significance of frequencies. Significant biases in the distribution of cases of babesiosis were found with regard to season (P < 0,05), sex (P < 0,001) and coat colour (P < 0.01).
[Equine piroplasmosis and nuttaliosis].
Veterinariia    September 1, 1979   Issue 9 40-41 
Nikol'skiĭ SN, Baturina FM, Lutsuk SN.No abstract available
Comparative serologic study of equine piroplasmosis, with card and complement-fixation tests.
American journal of veterinary research    April 1, 1979   Volume 40, Issue 4 529-531 
Amerault TE, Frerichs WM, Stiller D.An agglutinating antigen and a rapid card test (CT) for equine piroplasmosis was developed. The antigen for the CT was prepared from lyophilized Babesia caballi complement-fixation (CF) antigen. Serum and plasma samples for testing were obtained from known B caballi-infected horses and clinically normal horses maintained at the laboratory. Serum samples also were obtained from horses outside the continental United States, in areas where piroplasmosis is endemic. Comparative CT and CF tests were done on all samples. The CT correctly identified 85% of 192 plasma samples from known infected and n...
Prevalence of latent cases of Babesia equi infection in some parts of North West India as measured by the capillary agglutination test.
Equine veterinary journal    January 1, 1978   Volume 10, Issue 1 24-26 doi: 10.1111/j.2042-3306.1978.tb02209.x
Malhotra DV, Banerjee DP, Gautam OP.The prevalence of Babesia equi infection in north west India was assessed by means of the capillary tube agglutination (CA) test. The particulate antigen used in the test was potent and no cross reaction with other related haemaprotozoa was observed. The serological survey showed that from 323 horses from 3 localities there was an overall incidence of 50.1 per cent. In Haryana the incidence was 38.3 per cent in the 196 horses tested, in Uttar Pradesh it was 47.2 per cent from 72 animals and in Rajasthan it was 96.4 per cent from 55 horses.
[Piroplasmosis in racing-horses. A serologic study in Santiago race-tracks (author’s transl)].
Boletin chileno de parasitologia    January 1, 1977   Volume 32, Issue 1-2 21-22 
Correa J, Urcelay S, Rudolph W, Montes G.No abstract available
Babesiosis of a horse in Australia.
Australian veterinary journal    October 1, 1976   Volume 52, Issue 10 487 doi: 10.1111/j.1751-0813.1976.tb05412.x
Churchill RC, Best DR.No abstract available
Equine piroplasmosis: leukocytic response to Babesia equi (Laveran, 1901) infection in Chile.
The British veterinary journal    September 1, 1975   Volume 131, Issue 5 601-609 doi: 10.1016/s0007-1935(17)35194-1
Rudolph W, Correa J, Zurita L, Manley W.No abstract available
[Prevention of piroplasmosis].
Veterinariia    May 1, 1975   Issue 5 74-76 
Netsetskiĭ AM, Marutian EM, Neĭman PK.No abstract available
Experimental acute Babesia caballi infections. I. Red blood cell dynamics.
Experimental parasitology    February 1, 1975   Volume 37, Issue 1 67-77 doi: 10.1016/0014-4894(75)90053-3
Allen PC, Frerichs WM, Holbrook AA.No abstract available
Babesia of horses in Britain.
The Veterinary record    October 12, 1974   Volume 95, Issue 15 346-347 doi: 10.1136/vr.95.15.346
Barnett SF.No abstract available
Treatment of equine piroplasmosis (B caballi) with imidocarb dipropionate.
The Veterinary record    August 31, 1974   Volume 95, Issue 9 188-189 doi: 10.1136/vr.95.9.188
Frerichs WM, Holbrook AA.No abstract available
Equine piroplasmosis (Babesia equi): therapeutic trials of imidocarb dihydrochloride in horses and donkeys.
The Veterinary record    July 21, 1973   Volume 93, Issue 3 73-75 doi: 10.1136/vr.93.3.73
Frerichs WM, Allen PC, Holbrook AA.No abstract available